Chinese Academy of Medical Sciences, Fuwai Hospital
With
Peking University First Hospital
Peking Union Medical College Hospital
Beijing Hospital of Traditional Chinese Medicine
EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin on vascular function protection in hypertensive patients at low/moderate cardiovascular risk.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients must meet the hypertension with low or moderate cardiovascular risk following 2010 Guidelines for prevention and treatment of hypertension in China
You may not be if
Secondary Hypertension
Women who are pregnant or lactating
History of mental instability, or major psychiatric illness not adequately controlled and stable on therapy
Type 2 Diabetes
Active liver disease or impaired liver function tests
Impaired renal function
Uncontrolled cardiac arrhythmia
Patient who is unable to give informed consent
Any condition or situation, which in the opinion of the investigator, might pose a risk to the patient or confound the results of the study
Clareo Health | Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
